Related Experiment Video
Updated: Jul 23, 2025
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
657
Clinical development of mRNA therapies against solid tumors
Dawei Wu1, Lingfeng Hu2, Xin Wang1,3
1Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Journal of Hematology & Oncology
|July 18, 2023
Summary
Messenger RNA (mRNA) therapeutics are expanding into cancer treatment, with solid tumor development still in early stages. Key advancements include lipid-based delivery systems and personalized neoantigen strategies.
Area of Science:
- Biotechnology
- Oncology
- Therapeutics Development
Background:
- Messenger RNA (mRNA) therapeutics have gained significant traction in biopharmaceutical industries.
- The application of mRNA technology is expanding beyond infectious diseases into oncology.
- A comprehensive analysis of 108 clinical trials from 1999 to 2021 provides insights into this evolving field.
Discussion:
- Clinical development of mRNA therapies for solid tumors is nascent.
- Significant evolution observed in delivery systems, moving from dendritic cells to lipid-based platforms.
- Encoding strategies have advanced from fixed tumor antigens to personalized neoantigens.
Key Insights:
- mRNA cancer therapies are primarily focused on adjuvant or maintenance treatment roles.
- Combination therapies, particularly with checkpoint inhibitors, represent a major development trend.
- The field is characterized by rapid innovation in both delivery and targeting strategies.
Outlook:
- Continued growth is expected in mRNA-based cancer therapeutics.
- Further research into personalized neoantigen vaccines will likely drive clinical progress.
- Integration with immunotherapy, such as checkpoint inhibitors, holds significant promise for enhanced efficacy.
Related Concept Videos
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:29Microorganisms in Medicine and Therapeutics
60
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
60
01:27Tumor Immunotherapy
560
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
560
01:30Cancer Vaccines
410
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
410
00:59Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K